IT1206823B - Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche - Google Patents

Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Info

Publication number
IT1206823B
IT1206823B IT8748117A IT4811787A IT1206823B IT 1206823 B IT1206823 B IT 1206823B IT 8748117 A IT8748117 A IT 8748117A IT 4811787 A IT4811787 A IT 4811787A IT 1206823 B IT1206823 B IT 1206823B
Authority
IT
Italy
Prior art keywords
quote
therapeutic agents
diabetic complications
glycine derivatives
glycine
Prior art date
Application number
IT8748117A
Other languages
English (en)
Other versions
IT8748117A0 (it
Inventor
Murase Masao
Maruo Shigeaki
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of IT8748117A0 publication Critical patent/IT8748117A0/it
Application granted granted Critical
Publication of IT1206823B publication Critical patent/IT1206823B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8748117A 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche IT1206823B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15214986 1986-06-27

Publications (2)

Publication Number Publication Date
IT8748117A0 IT8748117A0 (it) 1987-06-26
IT1206823B true IT1206823B (it) 1989-05-03

Family

ID=15534103

Family Applications (2)

Application Number Title Priority Date Filing Date
IT8748116A IT1206822B (it) 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IT8748116A IT1206822B (it) 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche

Country Status (6)

Country Link
US (2) US4785018A (it)
JP (2) JPS6399057A (it)
DE (2) DE3721222A1 (it)
FR (2) FR2600647B1 (it)
GB (2) GB2192002B (it)
IT (2) IT1206822B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196849B (it) * 1986-12-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
US4962224A (en) * 1987-12-23 1990-10-09 American Home Products Corporation N-naphthoylglycines as aldose reductase inhibitors
CA1307537C (en) * 1987-12-23 1992-09-15 Jay E. Wrobel N-naphthoylglycines as aldose reductase inhibitors
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
IL124522A0 (en) * 1995-11-24 1998-12-06 Smithkline Beecham Spa Quinoline derivatives
WO1998041506A1 (en) * 1997-03-14 1998-09-24 Smithkline Beecham Corporation Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
WO2002098421A1 (en) * 2001-06-05 2002-12-12 University Of Maryland, Baltimore Novel treatment for neurological and psychiatric disorders
WO2006034491A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928610A (en) * 1970-06-06 1975-12-23 Hoechst Ag Benzene sulfonyl-urea preparation for treatment of diabetes mellitus and a method for treatment
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels
JPS5216367A (en) * 1975-07-21 1977-02-07 Rikagaku Kenkyusho Plant growth control agent
US4195984A (en) * 1979-03-12 1980-04-01 Abbott Laboratories Herbicides derived from dihalo isonicotinoyl derivatives of amino acids
AU544067B2 (en) * 1981-03-02 1985-05-16 Wyeth-Ayerst Canada Inc. Thioamides and amides. treatment of diabetes
CA1176269A (en) * 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
CA1182472A (en) * 1981-03-02 1985-02-12 Kazimir Sestanj N-[(2-naphthalenyl)thioxomethyl]glycine derivatives
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
US4604406A (en) * 1984-11-16 1986-08-05 Ayerst, Mckenna & Harrison, Inc. N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs

Also Published As

Publication number Publication date
FR2600647A1 (fr) 1987-12-31
IT8748117A0 (it) 1987-06-26
GB8715055D0 (en) 1987-08-05
FR2600646B1 (fr) 1990-01-26
DE3721222A1 (de) 1988-01-14
GB2192002B (en) 1990-04-11
DE3721223C2 (it) 1991-11-14
DE3721223A1 (de) 1988-01-14
JPS63119455A (ja) 1988-05-24
US4785018A (en) 1988-11-15
IT8748116A0 (it) 1987-06-26
GB8715056D0 (en) 1987-08-05
FR2600646A1 (fr) 1987-12-31
US4970214A (en) 1990-11-13
GB2193210B (en) 1990-03-28
FR2600647B1 (fr) 1991-10-18
IT1206822B (it) 1989-05-03
GB2193210A (en) 1988-02-03
GB2192002A (en) 1987-12-31
JPS6399057A (ja) 1988-04-30

Similar Documents

Publication Publication Date Title
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
MX161423A (es) Mejoras en aplicador transdermico de medicamento
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
AU589371B2 (en) Purine derivatives and use as therapeutic agent
KR890700360A (ko) 경피 흡수 촉진제 및 이를 함유하는 피부외용 제제
KR910700249A (ko) 신규 치료학적 활성 화합물 및 그의 제조 방법
DE69218932D1 (de) Transdermale therapeutische Formulierung
DK90089A (da) Hudbehandlingspraeparat
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
NZ223043A (en) Sialic acid derivatives; use as stabilisers for physiologically active substances and as binders in chromatography
DK565089D0 (da) Hudpraeparater
AU7426687A (en) Therapeutic agent for skin ulcers
ZA898201B (en) Gestodene-containing agent for transdermal administration
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
IT1206823B (it) Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche
FR2566662B1 (fr) Association medicamenteuse utilisee en photochimiotherapie
IT1157126B (it) N(vinblastin-23-il)derivati di aminoacidi loro preparazione ed applicazione terapeutica
BR8805129A (pt) Composicao cationicamente curavel e composicao fotocuravel
DK453688D0 (da) Farmaceutiske praeparater til topisk anvendelse
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
DK415087D0 (da) Terapeutiske midler indeholdende benzhydrylthiomethanderivater
AU2649288A (en) Transdermal absorptive drug formulation
IT1206023B (it) Derivati di acido benzoico quali agenti anti-iperlipemici e procedimento di preparazione
DK429589D0 (da) Transdermalt laegemiddelpraeparat
BR8601449A (pt) Reducao da velocidade de agentes de cura de diaminas alifaticas em cimentos de poliuretano

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19930419